RDY 611 (Pramipexole dihydrochloride extended-release 0. 375 mg)
Pill imprint RDY 611 has been identified as Pramipexole dihydrochloride extended-release 0. 375 mg.
Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0. 375 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- RDY 611
- Strength:
- 0. 375 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Dr. Reddy's Laboratories Limited
More about pramipexole
Consumer resources
- Other brands: Mirapex, Mirapex ER
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
